PPD, Inc. PPDI and Berry Consultants, LLC today announced they have entered into a collaboration in the area of Bayesian statistics, providing biopharmaceutical companies a way to improve the speed and quality of decision making for their clinical development programs.
As part of the agreement, Berry Consultants will collaborate with PPD in Bayesian design and analysis, areas of adaptive trial design that are bringing changes to how clinical research is conducted. In return, PPD will assist in expanding Berry Consultants' client base within the biopharmaceutical industry.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in